Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

These 4 'High-Potential' Biotech Stocks Could Outperform In 2013
Seeking Alpha
Thursday, April 18, 2013 - 6:57pm
tags:
Arena Pharmaceuticals, Gilead, Biomarin, Acadia, Catalyst Pharmaceutical Partners
Sinovac posts 4Q loss as expenses rise
Yahoo/AP
Thursday, April 18, 2013 - 6:56pm
tags:
earnings, Sinovac
FDA Says, "Call Me Maybe"
Motley Fool
Thursday, April 18, 2013 - 6:55pm
tags:
FDA, Sarepta, eteplirsen
Vertex Gains as Cystic Fibrosis Combo Eases Breathing
Bloomberg
Thursday, April 18, 2013 - 6:53pm
tags:
cystic fibrosis, Vertex Pharmaceuticals, Kalydeco
By Adding Cost Effective Suppliers, Amarin Looks To Gain Market Share With Vascepa
Seeking Alpha
Thursday, April 18, 2013 - 6:51pm
tags:
Amarin, Vascepa, Chemport
US panel divided over safety of Endo's testosterone drug
Reuters
Thursday, April 18, 2013 - 6:50pm
tags:
Endo Health Solutions, testosterone, Aveed, FDA, advisory panels
Antibiotics upstart Allecra snags €15M VC round amid superbug scare
Fierce Biotech
Thursday, April 18, 2013 - 10:51am
tags:
antibiotics, Allecra
Troubling New Signals? Diabetes Drugs & Adverse Event Reports
Pharmalot
Thursday, April 18, 2013 - 10:43am
tags:
adverse events, diabetes, FDA, Novo Nordisk, Bristol-Myers Squibb, Boehringer Ingelheim, Merck, Eli Lilly
Bayer, Amgen Face Price Cuts as German Panel Expands Drug Review
Bloomberg
Thursday, April 18, 2013 - 10:41am
tags:
Germany, Bayer, Amgen
Elan buyback priced at $11.25 reduces Royalty bid
Reuters
Thursday, April 18, 2013 - 10:39am
tags:
Royalty Pharma, Elan, stock buyback
Pfizer CEO Was Highest Paid Among Pharma Companies Last Year
Bloomberg
Thursday, April 18, 2013 - 10:37am
tags:
Pfizer, executive pay, Ian Read
Baxter posts lower earnings on acquisition-related expenses
Reuters
Thursday, April 18, 2013 - 8:37am
tags:
earnings, Baxter International
Cipla steamrolls into Enbrel market with biosimilar of Amgen drug
Fierce Pharma
Thursday, April 18, 2013 - 8:34am
tags:
Cipla, Enbrel, Amgen, biosimilars, India, anemia
Merck & Co. Picks Up Exclusive Option on Xenon CV Drugs
Genetic Engineering News
Thursday, April 18, 2013 - 8:22am
tags:
Merck, Xenon
GSK’s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment
Outsourcing Pharma
Thursday, April 18, 2013 - 8:21am
tags:
restless legs syndrome, GSK, CMOs, drug shortages, XenoPort, Astellas, Horizant
GTx And Trius Therapeutics: 2 Top Biotech Buys For 2013
Seeking Alpha
Thursday, April 18, 2013 - 8:05am
tags:
GTx, Trius Therapeutics, enobosarm, TR-701
Exact Sciences cancer test meets goal, but disappoints investors
Reuters
Thursday, April 18, 2013 - 8:03am
tags:
EXACT Sciences, colorectal cancer
Can Pfizer Keep Up The Positive Momentum?
Seeking Alpha
Thursday, April 18, 2013 - 8:01am
tags:
Pfizer
Declines From Sanofi Drive Down Drug Industry
TheStreet.com
Thursday, April 18, 2013 - 8:00am
tags:
Sanofi
How Big Will Johnson & Johnson’s Legal Bill Grow?
Wall St. Cheat Sheet
Thursday, April 18, 2013 - 7:58am
tags:
JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.